Yundong He

1.9k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Yundong He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yundong He has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Yundong He's work include Prostate Cancer Treatment and Research (12 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Yundong He is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Yundong He collaborates with scholars based in China, United States and Canada. Yundong He's co-authors include Haojie Huang, Yunqian Pan, Yu‐Tian Xiao, Shancheng Ren, Weidong Xu, Di Gu, Liguo Wang, Mingyao Liu, Zhengfang Yi and Yuqian Yan and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The EMBO Journal.

In The Last Decade

Yundong He

29 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

2022 149 citations Yundong He, Weidong Xu et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Yundong He

Since Specialization

Citations

This map shows the geographic impact of Yundong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yundong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yundong He more than expected).

Fields of papers citing papers by Yundong He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yundong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yundong He. The network helps show where Yundong He may publish in the future.

Co-authorship network of co-authors of Yundong He

This figure shows the co-authorship network connecting the top 25 collaborators of Yundong He. A scholar is included among the top collaborators of Yundong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yundong He. Yundong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and biological evaluation of carborane-containing derivatives as TEAD auto palmitoylation inhibitors 2025 ·Bioorganic & Medicinal Chemistry Letters ·Chaofan Li, Yingshuang Zhang, (unknown), (unknown), (unknown), Linyuan Wang, (unknown), Guangzhou Hao, Nan Sun, Hongjing Li, Zhiguang Zhang, Yundong He, Sinan Wang	1
2	Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer 2024 ·European Journal of Medicinal Chemistry ·Tian Guan, Yingshuang Zhang, Li Shen, (unknown), (unknown), Yuzhan Li, Yundong He, Yihua Chen	4
3	Advances in landscape and related therapeutic targets of the prostate tumor microenvironment 2023 ·Acta Biochimica et Biophysica Sinica ·(unknown), Weidong Xu, Yifan Chang, Yu‐Tian Xiao, Yundong He, (unknown)	16
4	Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4 2023 ·Genes & Diseases ·Mengmeng Guo, Pan Hu, (unknown), Kefu Tang, (unknown), (unknown), Yundong He, (unknown), Weiqiang Lü, Huirong Liu, Mingyao Liu, Zhengfang Yi, Shihong Peng	2
5	Cooperative control method considering efficiency and tracking performance for unmanned hybrid tractor based on rotary tillage prediction 2023 ·Energy ·Junjiang Zhang, (unknown), (unknown), Yundong He, Mengnan Liu, (unknown)	10
6	Targeting signaling pathways in prostate cancer: mechanisms and clinical trials breakdown → 2022 ·Signal Transduction and Targeted Therapy ·Yundong He, Weidong Xu, Yu‐Tian Xiao, Haojie Huang, Di Gu, Shancheng Ren	149
7	Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression 2021 ·Cancer Research ·Lei Shi, Yuqian Yan, Yundong He, Binyuan Yan, Yunqian Pan, Jacob J. Orme, Jun Zhang, Wanhai Xu, Jun Pang, Haojie Huang	25
8	Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG (Adv. Sci. 20/2021) 2021 ·Advanced Science ·(unknown), Yuqian Yan, Donglin Ding, Dejie Wang, Yundong He, Yunqian Pan, Wei Yan, Anupreet Kharbanda, Hongyu Li, Haojie Huang	1
9	Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122 2021 ·Frontiers in Oncology ·Xiaonan Cong, Yundong He, Haigang Wu, (unknown), Yongrui Liu, (unknown), Mingyao Liu, Zhengfang Yi, Jianghua Zheng, Shihong Peng, Tao Ding	5
10	A noncanonical AR addiction drives enzalutamide resistance in prostate cancer 2021 ·Nature Communications ·Yundong He, Ting Wei, Zhenqing Ye, Jacob J. Orme, Dong Lin, Haoyue Sheng, Ladan Fazli, R. Jeffrey Karnes, Rafael E. Jiménez, Liguo Wang, Liewei Wang, Martin Gleave, Yuzhuo Wang, Lei Shi, Haojie Huang	62
11	SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition 2021 ·Nature Communications ·Jian Ma, Qing Shi, Gaofeng Cui, Haoyue Sheng, Maria Victoria Botuyan, Yingke Zhou, Yuqian Yan, Yundong He, Liguo Wang, Yuzhuo Wang, Georges Mer, (unknown), Chenji Wang, Haojie Huang	17
12	Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain 2020 ·Cell Biology and Toxicology ·Shihong Peng, Jie Wang, Chen Huang, Pan Hu, Xiaolong He, Yundong He, (unknown), Wenshu Tang, (unknown), Yingying Wang, (unknown), Dandan Guo, Shancheng Ren, Mingyao Liu, Wen‐Wei Qiu, Zhengfang Yi	15
13	Torque Coordination Control of an Electro-Hydraulic Composite Brake System During Mode Switching Based on Braking Intention 2020 ·Energies ·Yang Yang, Yundong He, Yang Zhong, Chunyun Fu, (unknown)	22
14	EZH 2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis 2019 ·The EMBO Journal ·Yu Zhao, Liya Ding, Dejie Wang, Zhenqing Ye, Yundong He, Linlin Ma, Runzhi Zhu, Yunqian Pan, Qiang Wu, Kun Pang, Xiaonan Hou, Saravut J. Weroha, (unknown), Roger Coleman, Ilsa M. Coleman, R. Jeffery Karnes, Jun Zhang, Peter S. Nelson, Liguo Wang, Haojie Huang	60
15	A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer 2019 ·Journal of Experimental & Clinical Cancer Research ·Jinhua Wang, (unknown), Yingying Wang, Yundong He, Liting Wang, Shihong Peng, (unknown), (unknown), Xiaotao Li, Wen‐Wei Qiu, Zhengfang Yi, Mingyao Liu	21
16	TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer 2018 ·Clinical Cancer Research ·(unknown), Yundong He, Yinhui Yang, Zhenqing Ye, Yuqian Yan, Yunqian Pan, Tao Ma, (unknown), E. Wolfgang Kuehn, Manish Kohli, Rafael E. Jiménez, Yu Chen, Wanhai Xu, Liguo Wang, Haojie Huang	51
17	PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer 2017 ·Clinical Cancer Research ·Yinhui Yang, Yang Bai, Yundong He, Yu Zhao, Jiaxiang Chen, Linlin Ma, Yunqian Pan, Michael Hinten, Jun Zhang, R. Jeffrey Karnes, Manish Kohli, Jennifer J. Westendorf, Benyi Li, Runzhi Zhu, Haojie Huang, Wanhai Xu	50
18	Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion 2017 ·Cancer Research ·Yinhui Yang, (unknown), Dejie Wang, Jian An, Yunqian Pan, Yuqian Yan, Tao Ma, Yundong He, (unknown), Xiaonan Hou, (unknown), S. John Weroha, Wei‐Guo Zhu, Yanru Wang, Ronald A. DePinho, Wanhai Xu, Haojie Huang	47
19	Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer 2016 ·Nature Communications ·Yundong He, Shihong Peng, Jinhua Wang, Chen Huang, Xiaonan Cong, Ang Chen, Meichun Hu, Min Qin, Haigang Wu, (unknown), Liguo Wang, Xin Wang, Zhengfang Yi, Mingyao Liu	79
20	PubAngioGen: a database and knowledge for angiogenesis and related diseases 2014 ·Nucleic Acids Research ·Peng Li, Yongrui Liu, Huan Wang, Yuan He, Xue Wang, Yundong He, Fang Lv, Huaqing Chen, Xiufeng Pang, Mingyao Liu, Tieliu Shi, Zhengfang Yi	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact